| Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites GN Kalambokis, A Mouzaki, M Rodi, K Pappas, A Fotopoulos, X Xourgia, ... Clinical Gastroenterology and Hepatology 10 (7), 815-818, 2012 | 153 | 2012 |
| Clinical and immunological parameters of Sjögren's syndrome K Psianou, I Panagoulias, AD Papanastasiou, AL de Lastic, M Rodi, ... Autoimmunity reviews 17 (10), 1053-1064, 2018 | 137 | 2018 |
| Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia GN Kalambokis, A Mouzaki, M Rodi, EV Tsianos Liver International 32 (3), 467-475, 2012 | 55 | 2012 |
| Different immunosuppressive combinations on T-cell regulation in renal transplant recipients C Fourtounas, P Dousdampanis, P Sakellaraki, M Rodi, ... American Journal of Nephrology 32 (1), 1-9, 2010 | 55 | 2010 |
| Conjugation with polyamines enhances the antibacterial and anticancer activity of chloramphenicol ON Kostopoulou, EC Kouvela, GE Magoulas, T Garnelis, I Panagoulias, ... Nucleic Acids Research 42 (13), 8621-8634, 2014 | 41 | 2014 |
| Respiratory distress syndrome (RDS) in premature infants is underscored by the magnitude of Th1 cytokine polarization AA Varvarigou, I Thomas, M Rodi, I Economou, S Mantagos, A Mouzaki Cytokine 58 (3), 355-360, 2012 | 36 | 2012 |
| T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: can they predict outcome? D Kalavrizioti, M Gerolymos, M Rodi, P Kalliakmani, S Provatopoulou, ... Cytokine 76 (2), 260-269, 2015 | 35 | 2015 |
| Rifaximin for the prevention of spontaneous bacterial peritonitis GN Kalambokis, A Mouzaki, M Rodi, EV Tsianos World Journal of Gastroenterology: WJG 18 (14), 1700, 2012 | 35 | 2012 |
| Expression patterns of leptin receptor (OB-R) isoforms and direct in vitro effects of recombinant leptin on OB-R, leptin expression and cytokine secretion by human … A Mouzaki, I Panagoulias, Z Dervilli, V Zolota, P Spadidea, M Rodi, ... Cytokine 48 (3), 203-211, 2009 | 35 | 2009 |
| Immune parameters that distinguish multiple sclerosis patients from patients with other neurological disorders at presentation A Mouzaki, M Rodi, N Dimisianos, A Emmanuil, D Kalavrizioti, ... PLoS One 10 (8), e0135434, 2015 | 33 | 2015 |
| Synergistic effect of cold atmospheric pressure plasma and free or liposomal doxorubicin on melanoma cells K Pefani-Antimisiari, DK Athanasopoulos, A Marazioti, K Sklias, M Rodi, ... Scientific Reports 11 (1), 14788, 2021 | 31 | 2021 |
| Regulatory cell populations in relapsing-remitting multiple sclerosis (RRMS) patients: effect of disease activity and treatment regimens M Rodi, N Dimisianos, AL De Lastic, P Sakellaraki, G Deraos, ... International Journal of Molecular Sciences 17 (9), 1398, 2016 | 29 | 2016 |
| Fecal microbiota transplantation and hydrocortisone ameliorate intestinal barrier dysfunction and improve survival in a rat model of cecal ligation and puncture-induced sepsis SF Assimakopoulos, I Papadopoulou, D Bantouna, AL De Lastic, M Rodi, ... Shock 55 (5), 666-675, 2021 | 27 | 2021 |
| Cytokines as biomarkers of treatment response to IFNβ in relapsing-remitting multiple sclerosis N Dimisianos, M Rodi, D Kalavrizioti, V Georgiou, P Papathanasopoulos, ... Multiple Sclerosis International 2014, 2014 | 27 | 2014 |
| Properties of myelin altered peptide ligand cyclo (87-99)(Ala91, Ala96) MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis G Deraos, M Rodi, H Kalbacher, K Chatzantoni, F Karagiannis, ... European journal of medicinal chemistry 101, 13-23, 2015 | 24 | 2015 |
| Cellular Vesicles: New insights in engineering methods, interaction with cells and potential for brain targeting A Marazioti, K Papadia, M Kannavou, M Spella, A Basta, AL de Lastic, ... Journal of Pharmacology and Experimental Therapeutics 370 (3), 772-785, 2019 | 20 | 2019 |
| Design and Synthesis of Non-Peptide Mimetics Mapping the Immunodominant Myelin Basic Protein (MBP83–96) Epitope to Function as T-Cell Receptor Antagonists MP Yannakakis, C Simal, H Tzoupis, M Rodi, N Dargahi, M Prakash, ... International journal of molecular sciences 18 (6), 1215, 2017 | 18 | 2017 |
| Metabolic association between leptin and the corticotropin releasing hormone S Gioldasi, A Karvela, AP Rojas-Gil, M Rodi, AL de Lastic, I Thomas, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2019 | 12 | 2019 |
| Endotoxin translocation and gut barrier dysfunction are related to variceal bleeding in patients with liver cirrhosis C Triantos, M Kalafateli, SF Assimakopoulos, K Karaivazoglou, A Mantaka, ... Frontiers in Medicine 9, 836306, 2022 | 10 | 2022 |
| Effect of dendritic cell state and antigen-presentation conditions on resulting T-cell phenotypes and Th cytokine profiles AL de Lastic, M Rodi, A Mouzaki Immunobiology 221 (8), 862-870, 2016 | 10 | 2016 |
